Finance

Lists
Why is PHAR down 2,35%?
Dive Deeper
PHAR:NASDAQ
Pharming Group NV - ADR
9,75 $
-2,35%
(-0,23) 1D
10,00 $
+2,61% (+0,25)
After hours
Closed: 2 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAR...
Open
9,95 $
High
9,96 $
Low
9,75 $
Mkt. cap
629,65 մլն
Avg. vol.
30,23 հզր
Volume
12,41 հզր
52-wk high
21,30 $
52-wk low
9,63 $
Beta
-0,04
Shares outstanding
70,78 մլն
No. of employees
407
Open
9,95 $
High
9,96 $
Low
9,75 $
Mkt. cap
629,65 մլն
Avg. vol.
30,23 հզր
Volume
12,41 հզր
52-wk high
21,30 $
52-wk low
9,63 $
Beta
-0,04
Shares outstanding
70,78 մլն
No. of employees
407
News stories
From web sources and news partners
About Pharming Group NV - ADR
CEO-
Employees407
Founded1988
Headquarters-
Sector-
Websitepharming.com
Analyst ratings
Based on 2 analysts giving stock ratings to PHAR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PHAR in the last 3 months.
Highest
Current 9,75 $
38,00 $ (+289,74%)
Average
37,50 $ (+284,62%)
Lowest
37,00 $ (+279,49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Whitney Ijem
Canaccord Genuity
Buy
Maintained
38,00 $
+289,7%
09/29/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
37,00 $
+279,5%
09/30/2026
Jeff Jones
Oppenheimer
Buy
Maintained
40,00 $
+310,3%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
97,29 մլն
106,53 մլն
72,45 մլն
90,21 մլն
Cost of goods sold
7,07 մլն
21,13 մլն
6,64 մլն
14,54 մլն
Cost of revenue
7,07 մլն
21,13 մլն
6,64 մլն
14,54 մլն
Research and development expenses
21,28 մլն
32,05 մլն
25,56 մլն
32,26 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43,08 մլն
50,67 մլն
45,53 մլն
43,52 մլն
Operating expense
64,29 մլն
82,37 մլն
70,71 մլն
74,36 մլն
Total operating expenses
71,36 մլն
103,50 մլն
77,36 մլն
88,90 մլն
Operating income
25,92 մլն
3,03 մլն
-4,91 մլն
1,31 մլն
Other non operating income
1,88 մլն
403,00 հզր
-
-32,00 հզր
EBT including unusual items
12,76 մլն
4,80 մլն
-4,75 մլն
3,04 մլն
EBT excluding unusual items
22,86 մլն
1,61 մլն
-4,75 մլն
3,04 մլն
Income tax expense
5,21 մլն
-528,00 հզր
459,00 հզր
1,40 մլն
Effective tax rate
40,83%
-11,00%
-9,65%
46,12%
Other operating expenses
-71,00 հզր
-348,00 հզր
-377,00 հզր
-1,42 մլն
Net income
7,55 մլն
5,33 մլն
-5,21 մլն
1,64 մլն
Net profit margin
7,76%
5,00%
-7,20%
1,82%
Earnings per share
0,01
0,01
-0,07
0,00
Interest and investment income
-
4,50 մլն
3,24 մլն
-
Interest expense
-9,21 մլն
-
-2,70 մլն
-4,10 մլն
Net interest expenses
-9,21 մլն
4,50 մլն
542,00 հզր
-4,10 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
30,12 մլն
6,24 մլն
-1,80 մլն
2,67 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps